BY27
BY27 is a potent and selective BET bromodomain BD2 inhibitor (Ki = 3.1 nM) with demonstrated anticancer activity. It targets the second bromodomain (BD2) of BRD2, BRD3, BRD4, and BRDT, suppressing tumor growth in both cellular assays and in vivo models.
Product Specifications
CAS Number
2247236-59-3
Product Name Alternative
BD2, BY 27, BY27, BY-27, BRD4 BD2, BRD4 BD1, BRD2 BD1, BRD2 BD2, BRD3 BD1, BRD3 BD2, BRDT BD1, BRDT BD2, Epigenetic Reader Domain, EpigeneticReaderDomain
Field of Research
Epigenetics & Chromatin
Purity
99.19% (May vary between batches)
Smiles
N ([C@H]1C=2C (N3C (CC1) =NN=C3C) =CC=C (C2) C=4C=NN (C) C4) C5=CC=C (Cl) C=C5
Molecular Formula
C22H21ClN6
Molecular Weight
404.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![RACGAP1 Mouse Monoclonal Antibody [KD Validation]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MR206328L3V 200 µL
Sec14l4 (NM_146013) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 